Last updated on March 2019

A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: History of Myocardial Infarction | Hypertriglyceridemia
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Men and women 18 years of age
  • Patients with history of myocardial infarction not earlier than 6 months ago. AND/OR Patients with diagnosis of hypertriglyceridemia
  • Patients having been prescribed Omacor (Omega-3 triglycerides [EPA/DHA = 1.2/1 - 90%]) for at least 6 months AND who have been taking Omacor no more than 14 days at the time of enrollment into the program.
  • Patients who can, in the opinion of the Investigator, himself or through immediate relatives's help complete electronic system of data collection through mobile application or web-browser
  • Patients who have signed the consent to participate in this program before entering their data in the electronic Case Report Form (eCRF) and who understand their right to discontinue the program at any time

Exclusion Criteria:

  • Patients taken medicines (except for Omacor) or nutrition supplements containing omega-3 in any proportions at the time of enrollment into the program OR it has been less than 3 months since last dose of medicines or nutrition supplements containing omega-3 taken.
  • Female patients during pregnancy or breastfeeding
  • Patients with increased sensitivity to the active substance, excipients, and soy
  • Patients with exogenous hypertriglyceridemia (type I hyperchylomicronemia)
  • Participation in any other clinical or non-clinical study/program at present or within the latest 30 days
  • Patients with any other clinical states that make him/her ineligible for the program on the study doctor's opinion based on clinical assessment

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.